John Maslowski

President & CEO, Forge Biologics, A Member of Ajinomoto Bio-Pharma Services

John Maslowski is President and Chief Executive Officer of Forge Biologics, a Member of Ajinomoto Bio-Pharma Services, previously serving as Forge’s inaugural Chief Commercial Officer. He brings over 25 years of experience in pharmaceutical and biologics development, specializing in cell and gene therapy. Prior to Forge, he served as President & CEO of Castle Creek Biosciences, Inc. and Fibrocell Science, Inc., until Fibrocell was acquired in 2019.

Mr. Maslowski has held leadership roles at Wyeth Pharmaceuticals, Merck & Co., Inc., and Teva Pharmaceuticals Industries Ltd. He serves on the board of Debra of America and the Board of Advisors for Life Science Cares Philadelphia, and previously served on the board of the Alliance for Regenerative Medicine. Mr. Maslowski received his B.S. in biology from Ursinus College and his M.S. in microbiology from Villanova University.